{{Drugbox
| Watchedfields = changed
| verifiedrevid = 443835716
| IUPAC_name = 4-methoxynaphthalen-1-yl-(1-pentyl-2-methylindol-3-yl)methanone
| image = JWH-098_structure.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule II
| legal_UK = Class B
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 316189-74-9
| ATC_prefix =  
| ATC_suffix =  
| PubChem = 45272116
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID      = 24628229

<!--Chemical data-->
| C=26 | H=27 | N=1 | O=2 
| molecular_weight = 385.497 g/mol
| smiles = CCCCCn(c1C)c2ccccc2c1C(=O)c(ccc3OC)c4ccccc34
| StdInChI          = 1S/C26H27NO2/c1-4-5-10-17-27-18(2)25(22-13-8-9-14-23(22)27)26(28)21-15-16-24(29-3)20-12-7-6-11-19(20)21/h6-9,11-16H,4-5,10,17H2,1-3H3
| StdInChIKey       = CNTCHEBQQFICNR-UHFFFAOYSA-N
}}

'''JWH-098''' is a synthetic [[cannabinoid receptor]] [[agonist]] from the [[naphthoylindole]] family. It is the [[indole]] 2-methyl derivative of a closely related compound [[JWH-081]], but has markedly different affinity for the [[Cannabinoid receptor 1|CB<sub>1</sub>]] and [[Cannabinoid receptor 2|CB<sub>2</sub>]] receptors. While JWH-081 is around 10x selective for CB<sub>1</sub> over CB<sub>2</sub>, in JWH-098 this is reversed, and it is around 4 times weaker than JWH-081 at CB<sub>1</sub> while being six times more potent at CB<sub>2</sub>, giving it a slight selectivity for CB<sub>2</sub> overall. This makes JWH-098 a good example of how methylation of the indole 2-position in the naphthoylindole series tends to increase CB<sub>2</sub> affinity, but often at the expense of CB<sub>1</sub> binding.<ref>Huffman JW, ''et al.'' Structure–activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB<sub>2</sub> receptor agonists. ''Bioorganic and Medicinal Chemistry''. 2005; 13:89-112. {{PMID|15582455}}</ref> JWH-098 is illegal in Russia,<ref>{{cite web|url=http://www.government.ru/gov/results/8945/ |title=Постановление от 31 декабря 2009 г. № 1186 О внесении изменений в некоторые постановления Правительства Российской Федерации по вопросам, связанным с оборотом наркотических средств |publisher=Government.ru |date= |accessdate=2010-09-09}}</ref> Sweden,<ref>[http://www.riksdagen.se/webbnav/index.aspx?nid=3911&bet=1999:58 Svensk författningssamling]</ref> and the UK,<ref>[http://www.opsi.gov.uk/si/si2009/draft/ukdsi_9780111486610_en_1 The Misuse of Drugs Act 1971 (Amendment) Order 2009] {{webarchive|url=https://web.archive.org/web/20091103064955/http://www.opsi.gov.uk/si/si2009/draft/ukdsi_9780111486610_en_1 |date=2009-11-03 }}</ref> although it is unclear whether it has any history of human use.

==See also==
* [[JWH-007]]
* [[JWH-081]]

==References==
{{reflist}}

{{Cannabinoids}}

[[Category:JWH cannabinoids]]
[[Category:Naphthoylindoles]]
[[Category:Phenol ethers]]
[[Category:Designer drugs]]


{{cannabinoid-stub}}